PortfoliosLab logoPortfoliosLab logo
USLM vs. JANX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

USLM vs. JANX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United States Lime & Minerals, Inc. (USLM) and Janux Therapeutics, Inc. (JANX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

USLM vs. JANX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
USLM
United States Lime & Minerals, Inc.
13.48%-9.59%188.91%64.34%9.84%-8.79%
JANX
Janux Therapeutics, Inc.
5.14%-74.22%398.97%-18.53%-33.25%-21.55%

Fundamentals

Market Cap

USLM:

$3.90B

JANX:

$899.14M

EPS

USLM:

$4.67

JANX:

-$2.54

PS Ratio

USLM:

10.47

JANX:

50.29

PB Ratio

USLM:

6.19

JANX:

0.94

Total Revenue (TTM)

USLM:

$372.73M

JANX:

$17.88M

Gross Profit (TTM)

USLM:

$182.31M

JANX:

$8.44M

EBITDA (TTM)

USLM:

$186.33M

JANX:

-$144.65M

Returns By Period

In the year-to-date period, USLM achieves a 13.48% return, which is significantly higher than JANX's 5.14% return.


USLM

1D
3.98%
1M
8.23%
YTD
13.48%
6M
3.69%
1Y
49.16%
3Y*
64.91%
5Y*
38.39%
10Y*
29.24%

JANX

1D
4.39%
1M
8.12%
YTD
5.14%
6M
-38.78%
1Y
-45.88%
3Y*
6.24%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

USLM vs. JANX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

USLM
USLM Risk / Return Rank: 7878
Overall Rank
USLM Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
USLM Sortino Ratio Rank: 7575
Sortino Ratio Rank
USLM Omega Ratio Rank: 7272
Omega Ratio Rank
USLM Calmar Ratio Rank: 8181
Calmar Ratio Rank
USLM Martin Ratio Rank: 8181
Martin Ratio Rank

JANX
JANX Risk / Return Rank: 1818
Overall Rank
JANX Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
JANX Sortino Ratio Rank: 2222
Sortino Ratio Rank
JANX Omega Ratio Rank: 2020
Omega Ratio Rank
JANX Calmar Ratio Rank: 1616
Calmar Ratio Rank
JANX Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

USLM vs. JANX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United States Lime & Minerals, Inc. (USLM) and Janux Therapeutics, Inc. (JANX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


USLMJANXDifference

Sharpe ratio

Return per unit of total volatility

1.28

-0.58

+1.86

Sortino ratio

Return per unit of downside risk

1.87

-0.33

+2.20

Omega ratio

Gain probability vs. loss probability

1.23

0.94

+0.29

Calmar ratio

Return relative to maximum drawdown

2.40

-0.71

+3.12

Martin ratio

Return relative to average drawdown

6.50

-1.19

+7.69

USLM vs. JANX - Sharpe Ratio Comparison

The current USLM Sharpe Ratio is 1.28, which is higher than the JANX Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of USLM and JANX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


USLMJANXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.28

-0.58

+1.86

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.10

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.82

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

-0.08

+0.35

Correlation

The correlation between USLM and JANX is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

USLM vs. JANX - Dividend Comparison

USLM's dividend yield for the trailing twelve months is around 0.18%, while JANX has not paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
USLM
United States Lime & Minerals, Inc.
0.18%0.20%0.15%0.35%0.57%0.50%0.56%6.52%0.76%0.70%0.66%0.91%
JANX
Janux Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

USLM vs. JANX - Drawdown Comparison

The maximum USLM drawdown since its inception was -77.09%, smaller than the maximum JANX drawdown of -83.14%. Use the drawdown chart below to compare losses from any high point for USLM and JANX.


Loading graphics...

Drawdown Indicators


USLMJANXDifference

Max Drawdown

Largest peak-to-trough decline

-77.09%

-83.14%

+6.05%

Max Drawdown (1Y)

Largest decline over 1 year

-22.46%

-64.94%

+42.48%

Max Drawdown (5Y)

Largest decline over 5 years

-45.87%

Max Drawdown (10Y)

Largest decline over 10 years

-45.87%

Current Drawdown

Current decline from peak

-13.51%

-78.29%

+64.78%

Average Drawdown

Average peak-to-trough decline

-27.37%

-51.08%

+23.71%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.31%

39.01%

-30.70%

Volatility

USLM vs. JANX - Volatility Comparison

United States Lime & Minerals, Inc. (USLM) and Janux Therapeutics, Inc. (JANX) have volatilities of 12.79% and 12.78%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


USLMJANXDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.79%

12.78%

+0.01%

Volatility (6M)

Calculated over the trailing 6-month period

26.79%

86.72%

-59.93%

Volatility (1Y)

Calculated over the trailing 1-year period

38.59%

79.41%

-40.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

34.94%

133.55%

-98.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.89%

133.55%

-97.66%

Financials

USLM vs. JANX - Financials Comparison

This section allows you to compare key financial metrics between United States Lime & Minerals, Inc. and Janux Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00M100.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
87.94M
7.88M
(USLM) Total Revenue
(JANX) Total Revenue
Values in USD except per share items